Caudal Dexmedetomidine vs Ketamine for Postoperative Analgesia in Pediatric DDH Surgery

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age1-6
SponsorAssiut University

About this trial

This study compares two medicines, Dexmedetomidine and Ketamine, added to caudal Bupivacaine to control pain after hip surgery in children. We will check how well each medicine reduces pain, how long the pain relief lasts, and if children need extra pain medicine. The goal is to find the safest and most effective option for postoperative pain relief in children undergoing hip surgery.

Eligibility criteria

Qualifiers

Children aged 1 to 6 years undergoing surgery for developmental dysplasia of the hip

ASA physical status I or II

Parental or guardian informed consent obtained

Disqualifiers

Known allergy to local anesthetics, Dexmedetomidine, or Ketamine

Coagulopathy or bleeding disorders

Infection at the site of caudal injection

Neurological disorders

Trial design

Treatments tested in this trial

  • Dexmedetomidine
  • Ketamine
  • Bupivacaine

Treatment groups

54 Participants
are divided into 2 treatment groups

Sponsors and collaborators